Intellectus Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,029
Closed -$1.4M 271
2024
Q2
$1.4M Buy
6,029
+206
+4% +$47.8K 0.38% 71
2024
Q1
$1.26M Buy
5,823
+260
+5% +$56.1K 0.33% 87
2023
Q4
$1.44M Sell
5,563
-50
-0.9% -$12.9K 0.42% 70
2023
Q3
$1.44M Buy
5,613
+13
+0.2% +$3.34K 0.46% 57
2023
Q2
$1.6M Sell
5,600
-185
-3% -$52.7K 0.48% 55
2023
Q1
$1.61M Sell
5,785
-478
-8% -$133K 0.51% 57
2022
Q4
$1.73M Sell
6,263
-2,288
-27% -$634K 0.6% 48
2022
Q3
$2.28M Buy
8,551
+2,206
+35% +$589K 0.81% 30
2022
Q2
$1.29M Buy
6,345
+3,205
+102% +$654K 0.44% 65
2022
Q1
$661K Buy
3,140
+1,120
+55% +$236K 0.2% 133
2021
Q4
$485K Buy
2,020
+739
+58% +$177K 0.12% 181
2021
Q3
$363K Sell
1,281
-1,237
-49% -$351K 0.09% 215
2021
Q2
$872K Buy
2,518
+114
+5% +$39.5K 0.2% 134
2021
Q1
$673K Buy
2,404
+73
+3% +$20.4K 0.18% 154
2020
Q4
$571K Buy
2,331
+196
+9% +$48K 0.17% 150
2020
Q3
$606K Sell
2,135
-402
-16% -$114K 0.23% 122
2020
Q2
$679K Sell
2,537
-23
-0.9% -$6.16K 0.26% 118
2020
Q1
$810K Sell
2,560
-29
-1% -$9.18K 0.39% 74
2019
Q4
$768K Buy
2,589
+233
+10% +$69.1K 0.31% 106
2019
Q3
$549K Buy
2,356
+581
+33% +$135K 0.24% 129
2019
Q2
$415K Buy
1,775
+440
+33% +$103K 0.18% 141
2019
Q1
$316K Buy
1,335
+69
+5% +$16.3K 0.14% 159
2018
Q4
$381K Buy
1,266
+46
+4% +$13.8K 0.26% 85
2018
Q3
$431K Sell
1,220
-262
-18% -$92.6K 0.15% 158
2018
Q2
$430K Buy
1,482
+42
+3% +$12.2K 0.16% 150
2018
Q1
$394K Buy
1,440
+117
+9% +$32K 0.14% 164
2017
Q4
$421K Sell
1,323
-4
-0.3% -$1.27K 0.16% 151
2017
Q3
$416K Sell
1,327
-82
-6% -$25.7K 0.17% 141
2017
Q2
$382K Buy
1,409
+167
+13% +$45.3K 0.17% 139
2017
Q1
$340K Buy
1,242
+196
+19% +$53.7K 0.17% 137
2016
Q4
$297K Buy
+1,046
New +$297K 0.15% 140